Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126531751 | 12653175 | 1 | I | 20160809 | 20160815 | 20160815 | EXP | US-DSJP-DSU-2016-127134 | DAIICHI | 0.00 | Y | 0.00000 | 20160815 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126531751 | 12653175 | 1 | PS | WELCHOL | COLESEVELAM HYDROCHLORIDE | 1 | Oral | 625 MG, BID | 21176 | 625 | MG | TABLET | BID | ||||||
| 126531751 | 12653175 | 2 | C | LOSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Oral | 100/12.5MG, QD | 0 | 1 | DF | TABLET | QD | ||||||
| 126531751 | 12653175 | 3 | C | OXYBUTYNIN | OXYBUTYNIN | 1 | UNK | 0 | |||||||||||
| 126531751 | 12653175 | 4 | C | CARVEDILOL. | CARVEDILOL | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 126531751 | 12653175 | 5 | C | BENAZEPRIL | BENAZEPRIL HYDROCHLORIDE | 1 | Oral | 1 DF, QD | 0 | 1 | DF | QD | |||||||
| 126531751 | 12653175 | 6 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | Oral | 240 MG, QD | 0 | 240 | MG | TABLET | QD | ||||||
| 126531751 | 12653175 | 7 | C | MULTI VITAMIN | VITAMINS | 1 | Oral | 1 TABLET, QD | 0 | 1 | DF | QD | |||||||
| 126531751 | 12653175 | 8 | C | COENZYME Q10 | UBIDECARENONE | 1 | UNK | 0 | |||||||||||
| 126531751 | 12653175 | 9 | C | EYE HEALTH VITAMIN | 2 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126531751 | 12653175 | 1 | Hyperlipidaemia |
| 126531751 | 12653175 | 2 | Hypertension |
| 126531751 | 12653175 | 3 | Product used for unknown indication |
| 126531751 | 12653175 | 4 | Cardiac disorder |
| 126531751 | 12653175 | 5 | Product used for unknown indication |
| 126531751 | 12653175 | 6 | Product used for unknown indication |
| 126531751 | 12653175 | 7 | Supplementation therapy |
| 126531751 | 12653175 | 8 | Supplementation therapy |
| 126531751 | 12653175 | 9 | Supplementation therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126531751 | 12653175 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126531751 | 12653175 | Cardiac operation | |
| 126531751 | 12653175 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |